Suppr超能文献

动脉高血压患者血清中分子量为15kD的蛋白质成分的存在与血清对钠钾ATP酶的抑制作用之间是否存在关联?

[Is there a relation between the presence in the serum of patients with arterial hypertension of a protein component with molecular weight of 15 kD and the inhibitory effect of the serum on Na,K-ATPase?].

作者信息

Rogaeva E A, Perova N V, Aleksandrov A A, Oganov R G, Lopina O D

出版信息

Vopr Med Khim. 1987 Jul-Aug;33(4):34-9.

PMID:2821695
Abstract

Blood sera from patients with arterial hypertension exhibited more distinct inhibitory effect on purified Na+,K+-ATPase as compared with blood sera of healthy persons. Moreover, the fraction of 12-15 kDa protein components was usually increased in blood sera of the patients. At the same time, strong inhibition of the enzyme occurred after addition of blood sera which did not contain the protein fraction. The data obtained suggest that both these patterns--the degree of blood sera inhibitory effect on Na+,K+-ATPase activity and content of 12-15 kDa protein components in blood serum--should be considered as diagnostically valuable at early steps of development of hypertension.

摘要

与健康人的血清相比,动脉高血压患者的血清对纯化的钠钾ATP酶表现出更明显的抑制作用。此外,患者血清中12 - 15 kDa蛋白质成分的比例通常会增加。同时,添加不含该蛋白质成分的血清后,该酶也会受到强烈抑制。所获得的数据表明,这两种模式——血清对钠钾ATP酶活性的抑制程度以及血清中12 - 15 kDa蛋白质成分的含量——在高血压发展的早期阶段都应被视为具有诊断价值。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验